Effects of Nevirapine and Efavirenz on HDL Cholesterol Levels and Reverse Cholesterol Transport in Mice

OBJECTIVE: The mechanism by which non-nucleoside reverse transcriptase inhibitors (NNRTIs) increase HDL cholesterol (HDL-C) in HIV+ patients and the benefits of this with respect to cardiovascular risk are not known. Studies were conducted to test the hypothesis that NNRTIs have a beneficial effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tohyama, Junichiro, Billheimer, Jeffrey T., Fuki, Ilia V., Rothblat, George H., Rader, Daniel J., Millar, John S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2755296/
https://ncbi.nlm.nih.gov/pubmed/18990393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2008.09.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados